Overview

Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma

Status:
Terminated
Trial end date:
2018-11-09
Target enrollment:
Participant gender:
Summary
Participants enrolling on this study will receive standard of care chemotherapy for Wnt positive medulloblastoma without the radiation therapy or the weekly chemotherapy that is given during radiation therapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborator:
Matthew Larson Foundation
Treatments:
Cisplatin
Cyclophosphamide
Lomustine
Mesna
Vincristine